Russian Pharma Market 360°
Information, analytics, consulting, licensing and partnering for international market players
Portfolio analysis & market analytics
Evaluating commercial potential of your portfolio and optimal strategy for Russia and CIS
Matchmaking for products and companies
Profiling and introducing potential partners
Market entry services
Product registration, setting up offices, staffing and commercialization of products
Market Access, GR and state purchases
Customized solutions and regional access
Why you should work with us
We know the industry «inside-out»
All of our employees have years worked in international pharmaceutical companies in managerial positions in Russia, US and Europe in marketing, sales, business development and government relations. We best understand the business environment, opportunities, limitations, requirements and risks. Our reports and services are at international level of quality in terms of content and format.
We have complete and accurate information for making decisions
We work with many databases and sources, local and global, constantly updated. Our information resources include professionals from the industry — service providers, healthcare officials, patient associations, top level managers within companies. Our staff is multilingual allowing for wide scope of research. We and our partners have established footprint in many geographies.
We have our own professional network
We know key decision-makers in charge of corporate operation, licensing and partnering. We have access to key opinion leaders in medical and regulatory fields to aid with making decisions about product or technology prospects. We can easily conduct necessary market research, polls and surveys in order to support and justify strategic or tactical business decisions.
You may find this interesting:
Цены на лекарства выросли почти на 10%
Согласно данным аналитической компании AlphaRM, средняя цена за условную упаковку лекарственного препарата с января по ноябрь 2019 года достигла 245 рублей, что больше на 9% по сравнению…
Минфин разъяснил порядок применения ЕНВД при установлении этапности внедрения маркировки
Минфин разъяснил порядок применения специального налогового режима в виде ЕНВД в отношении предпринимательской…
Росздравнадзор рассказал об изменениях в порядке оказания бесплатной медпомощи
Росздравнадзор подготовил Памятку для граждан об изменениях в Программе государственных гарантий бесплатного оказания гражданам медицинской помощи.